It is a pharma private limited company based in Bhubaneswar, Orissa, India, established in 2010.
2010 | Bhubaneswar, Orissa, India | ActiveMoxie Pharmaceutical Private Limited, a active private limited company, was established on 24 March 2010 in Bhubaneswar, Orissa, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230OR2010PTC011766. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹3.45 M.
It upholds a compliant status. Its leadership includes Diwakar Tiwary (Director), Santosh Kumar Bajpay (Director), Anjan Kumar Dubey (Director). Past directors included Diwakar Tiwary, Shiva Shankar Dubey, Bidhu Bhusana Patra. It holds ₹1.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Plot-446, Chakeisiani, Bhubaneswar, Orissa, 751010.
U24230OR2010PTC011766
011766
24 March 2010
₹4.00 M
₹3.45 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Moxie Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Diwakar Tiwary | Director | 22 May 2019 | Current |
| Santosh Kumar Bajpay | Director | 27 Jun 2020 | Current |
| Anjan Kumar Dubey | Director | 08 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 08 Mar 2019 | Past |
| Pramod Abcsdd | Managing Director | 22 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Moxie Pharmaceutical Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2016, Moxie Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2021 | Others | ₹1.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Moxie Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Moxie Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moxie Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Moxie Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Moxie Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.50 M with Charge ID 100445848 was registered on 29 Jan 2021. was documented.
Santosh Kumar Bajpay was appointed as a Director was appointed as a Director on 27 Jun 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
Progress on Diwakar Tiwary was appointed as a Director was appointed as a Director on 22 May 2019 & has been associated with this company since 6 years 7 months . was documented.
Anjan Kumar Dubey was appointed as a Director was appointed as a Director on 08 Mar 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
The CIN of Moxie Pharmaceutical Private Limited is U24230OR2010PTC011766.
Moxie Pharmaceutical Private Limited is headquartered at Plot-446, Chakeisiani, Bhubaneswar, Orissa, 751010.
Moxie Pharmaceutical Private Limited was incorporated on 24 March 2010.
The current directors of Moxie Pharmaceutical Private Limited are
The primary industry of Moxie Pharmaceutical Private Limited is Trade.
Moxie Pharmaceutical Private Limited is unlisted.
The authorized capital of Moxie Pharmaceutical Private Limited is ₹4.00 M, and the paid-up capital is ₹3.45 M.
The compliance status of Moxie Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX